Dynavax Technologies Corp (DVAX)
11.85
+0.01
(+0.08%)
USD |
NASDAQ |
Apr 23, 14:54
Dynavax Technologies Total Long Term Debt (Quarterly): 222.70M for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 222.70M |
September 30, 2023 | 222.42M |
June 30, 2023 | 222.13M |
March 31, 2023 | 221.86M |
December 31, 2022 | 221.58M |
September 30, 2022 | 221.30M |
June 30, 2022 | 221.03M |
March 31, 2022 | 220.76M |
December 31, 2021 | 220.49M |
September 30, 2021 | 220.22M |
June 30, 2021 | 219.96M |
March 31, 2021 | 179.89M |
December 31, 2020 | 179.81M |
September 30, 2020 | 179.73M |
June 30, 2020 | 179.66M |
March 31, 2020 | 179.58M |
December 31, 2019 | 178.60M |
September 30, 2019 | 177.62M |
June 30, 2019 | 176.64M |
March 31, 2019 | 175.67M |
December 31, 2018 | 100.87M |
September 30, 2018 | 100.32M |
June 30, 2018 | 99.77M |
March 31, 2018 | 99.23M |
December 31, 2017 | 0.00 |
Date | Value |
---|---|
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 9.459M |
March 31, 2015 | 9.507M |
December 31, 2014 | 9.559M |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 14.45M |
June 30, 2012 | 0.00 |
March 31, 2012 | 13.36M |
December 31, 2011 | 12.81M |
September 30, 2011 | 12.34M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
176.64M
Minimum
Jun 2019
222.70M
Maximum
Dec 2023
203.47M
Average
220.22M
Median
Sep 2021
Total Long Term Debt (Quarterly) Benchmarks
Supernus Pharmaceuticals Inc | 0.00 |
Ligand Pharmaceuticals Inc | 0.00 |
Pacira BioSciences Inc | 522.44M |
Esperion Therapeutics Inc | 261.60M |
PetIQ Inc | 446.42M |